A scoping review of interventions to prevent and treat adverse events during treatment of rifampin-susceptible tuberculosis. [PDF]
Burman WJ +5 more
europepmc +1 more source
Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae [PDF]
F Tuban +2 more
openalex +1 more source
Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series. [PDF]
Houwen JPA +6 more
europepmc +1 more source
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin [PDF]
Anna Żaczek +4 more
openalex +1 more source
Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions. [PDF]
Tian DD, Hall SD, Chapman SC, Posada MM.
europepmc +1 more source
Overcoming Treatment Challenges in HIV-Associated Mycobacterial Diseases: New Therapeutic Frontiers. [PDF]
Nikjeh O +3 more
europepmc +1 more source
Comparative in silico analysis of vapBC3 toxin-antitoxin system in Mycobacterium Bovis and Mycobacterium tuberculosis. [PDF]
Shafipour M +4 more
europepmc +1 more source

